Mayne Pharma (ASX: MYX) Threatens to Terminate A$672M Cosette Deal- Is the Stock a Buy at A$3.39?

The tables have turned, and shareholders face a key decision as the 10 December deadline approaches. Mayne Pharma (ASX: MYX) has turned the tables on US suitor Cosette Pharmaceuticals, issuing…

ByUjjwal Maheshwari

31

Oct 2025

Healthcare Stocks Market news

Mayne Pharma Collapses 30% as Treasurer Flags National-Interest Block in Cosette Deal

Mayne Pharma in Freefall: Regulatory Hurdle Threatens $672 m Buy-out Mayne Pharma (ASX: MYX) has suddenly become one of the most talked-about stocks on the ASX after the federal Treasurer raised…

ByCharlie Youlden

17

Mar 2025

Blue Chip Stocks Market news Mid Cap Stocks News Undervalued Stocks

It is only March, but there 6 ASX stocks have received takeover bids! What will happen to them?

6 ASX stocks that have received takeover bids already in 2025 Dropsuite (ASX:DSE) Unlike other bids which we will list, this offer will be going ahead with this company having…

ByNick Sundich

Mayne Pharma (ASX: MYX) Threatens to Terminate A$672M Cosette Deal- Is the Stock a Buy at A$3.39?

Mayne Pharma Collapses 30% as Treasurer Flags National-Interest Block in Cosette Deal

It is only March, but there 6 ASX stocks have received takeover bids! What will happen to them?

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Mayne Pharma (ASX: MYX) Threatens to Terminate A$672M Cosette Deal- Is the Stock a Buy at A$3.39?

Mayne Pharma Collapses 30% as Treasurer Flags National-Interest Block in Cosette Deal

It is only March, but there 6 ASX stocks have received takeover bids! What will happen to them?

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here